Impact of preoperative immunonutrition on recovery after bladder surgery
Official title: The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy - A Multicenter Randomized Controlled Trial (INCyst Trial)
Run by Centre Hospitalier Universitaire Vaudois · NCT05726786 · Data updated 2026-11-12
This study tests if special nutritional drinks before bladder surgery can help patients recover better and have fewer complications afterward.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 232 (estimated) |
| Sponsor | Centre Hospitalier Universitaire Vaudois Academic / other |
| Locations | 4 sites (Lausanne, Canton of Vaud and 3 other locations) |
| Status | Recruiting |
| Started | April 10, 2023 |
| Main results expected | August 2026 |
| Study ends | October 2026 |
| Registry record updated | December 9, 2025 |
| Trial ID | NCT05726786 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who are scheduled for open cystectomy.
✕Probably not a fit
Patients with contraindications to immunonutrition or those with severe concurrent diseases affecting immunity may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effects of preoperative oral immunonutrition on postoperative complications in patients undergoing cystectomy for bladder-related conditions. It is a multicentric, prospective, controlled study that aims to determine whether immunonutrition can reduce morbidity and improve immune response after surgery. The study will also seek to identify which patients are most likely to benefit from this nutritional intervention. By comparing outcomes across different centers, the trial aims to provide robust evidence on the efficacy of immunonutrition in this surgical context.
Why it matters
Potential benefit: If successful, this approach could significantly reduce postoperative complications and improve recovery for patients undergoing cystectomy.
How similar studies have gone: Previous studies have shown that preoperative immunonutrition can reduce complications in major surgeries, but specific evidence for cystectomy patients is limited, making this approach novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient undergoing open cystectomy (for all reasons) * Age ≥18 years * Ability and willingness to provide informed consent documented by signature Exclusion Criteria: * Contraindications to IN, e.g. known hypersensitivity or allergy to lactose, fish oil or soy lecithin * Severe diarrhoea requiring medical attention * Current treatment with any immunosuppressive drug * In standard practice, pregnant or lactating women are systematically rejected by the surgeon for this surgical procedure. Furthermore, during the pre-surgical anaesthesia consultation, the eligibility of each patient for anaesthesia will be assessed according to the usual criteria and recommendations of the anaesthesia service of the CHUV * Other clinically significant concomitant disease affecting immunity (e.g., severe renal failure, HIV, SLE, transplant recipient, ...) * Inability to follow the procedures of the study, e.g. due psychological disorders, dementia, etc. * Participation in another study with investigational drug within the 30 days preceding and during the present study * Previous enrolment into the current study * Use of IN independently of the study * Enrolment of the investigator, his/her family members, employees and other dependent persons * Emergency procedure (less than 7 days between screening and surgery)
Where it's running
-
Centre Hospitalier Universitaire Vaudois, CHUV
Lausanne, Canton of Vaud, Switzerland Recruiting -
University Hospital of Bern
Bern, Switzerland Recruiting -
University Hospital of Geneva
Geneva, Switzerland Recruiting -
Hospital of Riviera-Chablais
Rennaz, Switzerland Recruiting
Study contacts
- Study coordinator: Ilaria Lucca, MD
- Email: ilaria.lucca@chuv.ch
- Phone: +41213142980
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating a catheter-free method for bladder medication delivery
This study is testing a new way to deliver bladder medication without a catheter to see if it’s more comfortable and safer for people with conditions like interstitial cystitis and recurrent urinary tract infections.
-
Comparing different techniques to treat endometriosis
This study is testing different methods to treat endometriosis, like laser and heat techniques, to see which one works best for relieving pain in women who are already having surgery for the condition.
-
Transplantation of Bladders or Kidneys with Bladders from Deceased Donors
This study is testing if transplanting bladders from deceased donors can help people with severe bladder diseases, including those who need both a kidney and bladder transplant.
-
Assessing pain types in treating bladder pain syndrome
This study is trying to see how different types of bladder pain affect how well people with bladder pain syndrome respond to pelvic floor physical therapy and cognitive-behavioral therapy.
-
Tracking quality of life and relapses in bladder cancer patients after surgery
This study is tracking how bladder cancer patients feel and whether their cancer comes back after surgery over the next 10 years.
-
Using amniotic membrane therapy to treat interstitial cystitis and painful bladder syndrome
This study is testing whether injections of amniotic membrane therapy can help people with interstitial cystitis and painful bladder syndrome feel less pain and improve their urinary symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.